Increased copper ligand reactivity in the urine of patients with rheumatoid arthritis
β Scribed by Donald A. Gerber
- Publisher
- John Wiley and Sons
- Year
- 1966
- Tongue
- English
- Weight
- 570 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
β¦ Synopsis
By DONALD A. GERBER umIc ION^ and drugs modifying the C course of rheumatoid arthritW4 have been shown to have in common the ability to alter sulfhydryl group reactivity.
The following studies were performed to determine whether patients with rheumatoid arthritis excrete in their urine increased amounts of substances that alter the reactivity of cupric ion.
Methods
Biscyclohexanoneoxaldihydrazone (cuprizone)' reacts with the cupric ion to give a clear, stable, blue-colored solution with a constant absorbance over a pH range of 7.0 to 9.0. Cuprizone does not give a color with any other cations or anions commonly encountered in biological materials.5 The extent to which an aliquot of urine can suppress this color formation has been used as a measure of the concentration of copper ligand reactivity in urine. A copper ligand in this sense is defined as a substance which binds to copper. In the method devised, three stock solutions were prepared. Solution A: 0.5 ml. 0.02 M CuSO, + 295 ml. 0.1 M phosphate buffer (pH 7.4) + 4.7 ml. 1.0 M sodium citrate. Solution B: 10 m q cuprizoue
π SIMILAR VOLUMES
We investigated cellular phenotypes and expression of class I1 major histocompatibility complex antigens on endothelium and cellular infiltrates in synovium from patients with rheumatoid arthritis (RA) or reactive arthritis, using an indirect immunoperoxidase technique. The RA specimens showed synov
## Abstract The finding of an abnormal macroglobulin in the serum of patients with rheumatoid arthritis has been isolated and characterized by several groups of investigators. A study was undertaken to study other biological fluids as to the presence of this abnormal globulin. Spinal fluids and uri
Objective. To investigate the expression and function of Fas ligand (FasL),which can be in a membranebound or soluble form, in the joints of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Methods. The concentration of soluble FasL (sFasL) in serum and synovial fluid (SF) from 24 O